We have to consider both the upside and downside risks overall. Not everything in one basket. People have to understand the risks of voting No. If pfizer willing to increase the bid to the highest end of the IER before the meeting, then it is a win for everyone. Otherwise we still need to reconsider our vote on the day to limit our risk exposure.
- Forums
- ASX - By Stock
- RAP
- Valuing ResApp Health
Valuing ResApp Health, page-412
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)